Q1 2023 EPS Estimates for Axsome Therapeutics, Inc. (NASDAQ:

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – HC Wainwright reduced their Q1 2023 EPS estimates for shares of Axsome Therapeutics in a research report issued to clients and investors on Monday, March 20th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings per share of ($1.40) for the quarter, down […]

Related Keywords

Arizona , United States , , Nasdaq , Axsome Therapeutics Company Profile , Life Insurance Co , Pricet Rowe Associates Inc , Axsome Therapeutics Inc , Morgan Stanley , Group Plc , Axsome Therapeutics , Get Rating , Axsome Therapeutic , General Group Plc , Arizona State Retirement System , State Retirement System , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm , Axsm , Medical , Earnings Estimates , Hc Wainwright ,